StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Regeneron Pharma (REGN) Easily Tops Q4 EPS Views; Guides FY14 EYLEA Sales
February 11, 2014 6:32 AM
(Updated - February 11, 2014 6:53 AM EST)
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q4 EPS of $2.24, $1.27 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Earnings
FDA
Guidance
Hot Corp. News
Hot Earnings
Management Comments
Next Articles
BofA/Merrill Lynch Reinstated Regeneron Pharma (REGN) at Buy
February 12, 2014 6:49 AM
Regeneron Pharma (REGN) PT Raised to $410 at Deutsche Bank
February 11, 2014 2:32 PM
Regeneron Pharma (REGN) May Have Upside From Taxes - Analyst
February 11, 2014 10:36 AM